Working… Menu

Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02593045
Recruitment Status : Active, not recruiting
First Posted : October 30, 2015
Last Update Posted : February 12, 2019
Information provided by (Responsible Party):
Innate Pharma